| CB | HAPLO | |
|---|---|---|
| Age (median, years) | 3.9 (0.32-13.2) | 10 (0.3-36.3) |
| Underlying disease (n°) | Malignant 11/13 (84.6%); Non-malignant 2/13 (15.4%) | Malignant 34/45 (75.5%); Non-malignant 11/45 (24.5%) |
| Donor (n°) | UCB 11/13 (84.6%); Related CB (sibling) 2/13 (15.4%) | Mother 20/49 (40.8%); Father 26/49 (53.1%); Other 3/49 (6.1%) |
| Graft failure (n°) | 3/13 (23.1%) | 4/49 (8.1%) |
| Early viral reactivation (CMV, EBV, Adenovirus) (n°) | 6/13 (46.1%) | 24/49 (48.9%) |
| Early onset bacterial/Fungal infection (n°) | 2/13 (15.4%) | 8/49 (16.3%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.